Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3043% below fair value
$80.79−4.78 (-5.59%)
Close on Nov 19, 2026Market cap $33.38BP/E 13.3Yield 2.51%
Zoetis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Zoetis's pe ratio was 13.5× on Nov 11, 2026, against 21.8× a year earlier. Over the last 5 years it ranged from 11.4× to 58.8×, with a median of 33.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.5× | −7.9 |
| 2025 | Dec 31, 2025 | 21.4× | −9.3 |
| 2024 | Dec 31, 2024 | 30.6× | −9.5 |
| 2023 | Dec 29, 2023 | 40.1× | +6.7 |
| 2022 | Dec 30, 2022 | 33.5× | −25.3 |
| 2021 | Dec 31, 2021 | 58.8× | +11.1 |
| 2020 | Dec 31, 2020 | 47.7× | +4.0 |
| 2019 | Dec 31, 2019 | 43.7× | +7.7 |
| 2018 | Dec 31, 2018 | 35.9× | −2.0 |
| 2017 | Dec 29, 2017 | 37.9× | −0.9 |
| 2016 | Dec 30, 2016 | 38.8× | −15.1 |
| 2015 | Dec 31, 2015 | 53.8× | +15.4 |
| 2014 | Dec 31, 2014 | 38.4× | −3.5 |
| 2013 | Dec 31, 2013 | 41.9× | – |
See a number that looks wrong?